title: Intensity modulated radiation therapy allows prostate and dose-escalated pelvic radical radiation therapy after renal transplantation.
authors.affiliation: Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: nrosenfelder@gmail.com.
authors.forename: Nicola
authors.initials: N
authors.lastname: Rosenfelder
authors.affiliation: Renal Unit, Imperial College Healthcare NHS Trust, London, United Kingdom.
authors.forename: Richard
authors.initials: R
authors.lastname: Corbett
authors.affiliation: Physics Department, Royal Marsden NHS Foundation Trust, London, United Kingdom.
authors.forename: Michelle
authors.initials: M
authors.lastname: Long
authors.affiliation: Physics Department, Royal Marsden NHS Foundation Trust, London, United Kingdom.
authors.forename: Carole
authors.initials: C
authors.lastname: Meehan
authors.affiliation: Renal Unit, Imperial College Healthcare NHS Trust, London, United Kingdom.
authors.forename: Neill
authors.initials: N
authors.lastname: Duncan
authors.affiliation: Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
authors.forename: Vincent
authors.initials: V
authors.lastname: Khoo
authors.affiliation: Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Van As
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D058958:Organs at Risk; D010388:Pelvis / Q000528:radiation effects; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*
chemical_list: D007166:Immunosuppressive Agents